Epstein-barr virus gene expression, human leukocyte antigen alleles and chronic high viral loads in pediatric renal transplant patients

Transplantation

Volumn 92, Issue 3, 2011, Pages 328-333

  Moran, Julie ^a   Carr, Michael ^a   Waters, Allison ^a   Boyle, Sheila ^b   Riordan, Michael ^a   Connell, Jeff ^a   Awan, Atif ^b   Hall, William ^a   Hassan, Jaythoon ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

EBV; Gene expression; HLA allele; T cell

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; MESSENGER RNA; MYCOPHENOLIC ACID; PREDNISOLONE; SMALL RNA 1; TACROLIMUS; UNCLASSIFIED DRUG; VALACICLOVIR; VIRUS RNA;

ALLELE; ARTICLE; BART GENE; BZLF1 GENE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; EBNA1 GENE; EBNA2 GENE; EPSTEIN BARR VIRUS INFECTION; FEMALE; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GRAFT RECIPIENT; HLA SYSTEM; HUMAN; HUMAN CELL; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LMP1 GENE; LMP2 GENE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; T LYMPHOCYTE; VIRUS GENE; VIRUS LOAD;

ADOLESCENT; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HLA ANTIGENS; HUMANS; INFANT; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD;

EID: 79961037607     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182247bf2     Document Type: Article

References (22)

1. Henle W, Henle G, Lennette ET. The Epstein-Barr virus. Sci Am 1979; 241: 48.
2. Sixbey JW, Nedrud JG, Raab-Traub N, et al. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984; 310: 1225.
3. Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 1997; 15: 405.
4. Khanna R, Moss DJ, Burrows SR. Vaccine strategies against Epstein-Barr virus-associated diseases: Lessons from studies on cytotoxic T-cell-mediated immune regulation. Immunol Rev 1999; 170: 49.
5. Tan LC, Gudgeon N, Annels NE, et al. A re-evaluation of the frequency of CD8+T cells specific for EBV in healthy virus carriers. J Immunol 1999; 162: 1827.
6. Benninger-Doring G, Pepperl S, Deml L, et al. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers. Virology 1999; 264: 289.
7. Nalesnik MA. Clinicopathologic characteristics of post-transplant lymphoproliferative disorders. Recent Results Cancer Res 2002; 159: 9.
8. Young L, Alfieri C, Hennessy K, et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 1989; 321: 1080.
9. Takada K, Shimizu N, Sakuma S, et al. trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol 1986; 57: 1016.
10. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000; 343: 481.
11. Babcock GJ, Decker LL, Volk M, et al. EBV persistence in memory B cells in vivo. Immunity 1998; 9: 395.
12. Tao Q, Robertson KD, Manns A, et al. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: Molecular analysis of primary tumor tissue. Blood 1998; 91: 1373.
13. Deacon EM, Pallesen G, Niedobitek G, et al. Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells. J Exp Med 1993; 177: 339.
14. Brooks L, Yao QY, Rickinson AB, et al. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 1992; 66: 2689.
15. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004; 350: 1328.
16. Gotoh K, Ito Y, Ohta R, et al. Immunologic and virologic analyses in pediatric liver transplant recipients with chronic high Epstein-Barr virus loads. J Infect Dis 2010; 202: 461.
17. Iwata S, Wada K, Tobita S, et al. Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection. J Gen Virol 2010; 91(Pt 1): 42.
18. Qu L, Green M, Webber S, et al. Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads. J Infect Dis 2000; 182: 1013.
19. Smets F, Latinne D, Bazin H, et al. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 2002; 73: 1603.
20. Wheless SA, Gulley ML, Raab-Traub N, et al. Post-transplantation lymphoproliferative disease: Epstein-Barr virus DNA levels, HLA-A3, and survival. Am J Respir Crit Care Med 2008; 178: 1060.
21. Pourfarziani V, Einollahi B, Taheri S, et al. Associations of Human Leukocyte Antigen (HLA) haplotypes with risk of developing lymphoproliferative disorders after renal transplantation. Ann Transplant 2007; 12: 16.
22. Kubota N, Wada K, Ito Y, et al. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection. J Virol Methods 2008; 147: 26.